CD14 and neoplasm: Similar changes of surface markers on CD14+ monocytes were also observed in the co-cultures of tumor cells and purified monocytes with cetuximab in the absence of NK cells (Fig. 5c and d), indicating M1/M2 skewing of naïve monocytes altered by cetuximab is NK-independent.